Ryan J. Uitti

Active 1986–2025

126
Papers
20,724
Citations
82
h-index
125
i10-index

Citations

Citations per year for Ryan J. Uitti1967: 1 citations1987: 2 citations1988: 1 citations1989: 4 citations1990: 5 citations1991: 11 citations1992: 6 citations1993: 5 citations1994: 9 citations1995: 9 citations1996: 15 citations1997: 26 citations1998: 31 citations1999: 30 citations2000: 33 citations2001: 42 citations2002: 46 citations2003: 55 citations2004: 46 citations2005: 118 citations2006: 138 citations2007: 196 citations2008: 178 citations2009: 188 citations2010: 188 citations2011: 213 citations2012: 265 citations2013: 283 citations2014: 277 citations2015: 262 citations2016: 255 citations2017: 341 citations2018: 267 citations2019: 756 citations2020: 719 citations2021: 753 citations2022: 573 citations2023: 443 citations2024: 735 citations2025: 324 citations2026: 4 citations1968–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,012 citing papers, 27.1% of this breakdownUnited Kingdom: 1,059 citing papers, 9.5% of this breakdownGermany: 817 citing papers, 7.3% of this breakdownChina: 588 citing papers, 5.3% of this breakdownItaly: 537 citing papers, 4.8% of this breakdownCanada: 534 citing papers, 4.8% of this breakdownFrance: 370 citing papers, 3.3% of this breakdownJapan: 366 citing papers, 3.3% of this breakdownSpain: 350 citing papers, 3.1% of this breakdownAustralia: 323 citing papers, 2.9% of this breakdownNetherlands: 310 citing papers, 2.8% of this breakdownSweden: 246 citing papers, 2.2% of this breakdown
0%27.1%Other 23.6%

Fields

  • Medicine68.3%
  • Biochemistry, Genetics and Molecular Biology14.7%
  • Neuroscience13.6%
  • Immunology and Microbiology0.9%
  • Nursing0.5%
  • Psychology0.3%
  • Other1.7%

Topics

  • Parkinson's Disease Mechanisms and Treatments18.2%
  • Alzheimer's disease research and treatments7.4%
  • Neurological disorders and treatments7.1%
  • Neurological diseases and metabolism4.4%
  • Neuroinflammation and Neurodegeneration Mechanisms4%
  • Amyotrophic Lateral Sclerosis Research3.6%
  • Other55.3%

Coauthors

All papers

Open in search
  1. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neuron 2004 cited by 3,054

  2. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nigel Williams, Karen Morrison, Carl E Clarke, Kirsten Harvey, Benjamin M. Jacobs, Alexis Brice, Fabrice Danjou, Suzanne Lesage, Jean‐Christophe Corvol, María Martínez, Claudia Schulte, Kathrin Brockmann, Javier Simón‐Sánchez, Peter Heutink, Patrizia Rizzu, Manu Sharma, Thomas Gasser, Susanne A. Schneider, Mark Cookson, Cornelis Blauwendraat, David W. Craig, Kimberley J. Billingsley, Mary B. Makarious, Derek P. Narendra, Faraz Faghri, J. Raphael Gibbs, Dena Hernández, Kendall Van Keuren‐Jensen, Joshua Shulman, Hirotaka Iwaki, Hampton L. Leonard, Mike A. Nalls, Laurie Robak, José Brás, Rita Guerreiro, Steven Lubbe, Timothy Troycoco, Steven Finkbeiner, Niccolò E. Mencacci, Codrin Lungu, Andrew Singleton, Sonja W. Scholz, Xylena Reed, Ryan J. Uitti, Owen A. Ross, Francis P. Grenn, Anni Moore, Roy N. Alcalay, Zbigniew K. Wszołek, Ziv Gan‐Or, Guy A. Rouleau, Lynne Krohn, Kheireddin Mufti, Jacobus J. van Hilten, Johan Marinus, Astrid D. Adarmes-Gómez, Miquel Aguilar, Ignacio Álvarez, Victoria Álvarez, Francisco Javier Barrero, Jesús Alberto Bergareche Yarza, Inmaculada Bernal‐Bernal, Marta Blázquez Estrada, Marta Bonilla‐Toribio, Juan A. Botía, María Teresa Boungiorno, Dolores Buiza‐Rueda, Ana Cámara, Fátima Carrillo, Mario Carrión‐Claro and 75 more - Nature Communications 2021 cited by 214

  3. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shawn Levy, Daniel F. Broderick, Neill R. Graff‐Radford, Owen A. Ross, Bradley B. Miller, Russell H. Swerdlow, Dennis W. Dickson, Zbigniew K. Wszołek - Nature Genetics 2011 cited by 579

  4. VPS35 Mutations in Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zbigniew K. Wszołek, François Vingerhoets, Matthew J. Farrer - The American Journal of Human Genetics 2011 cited by 893

  5. APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology

    Authors: , , , , , , , , , , , , , , , , - Neurology 2018 cited by 222

  6. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Singleton, Matthew J. Farrer, Chang-En Yu, Lawrence I. Golbe, Tamás Révész, John Hardy, Andrew J. Lees, Bernie Devlin, Håkon Håkonarson, Ulrich Müller, Gerard D Schellenberg - Nature Genetics 2011 cited by 632

  7. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis W. Dickson, Rosa Rademakers, Owen A. Ross - Molecular Neurodegeneration 2013 cited by 413

  8. Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution

    Authors: , , , , , , , , , , , , , , , , , , - Neurology 2020 cited by 108

  9. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathrin M. Buetefisch, Robert E. Gross, Corneliu Luca, Jonathan Jagid, Gonzalo J. Revuelta, István Takács, Michael Pourfar, Alon Y. Mogilner, Andrew P. Duker, George Mandybur, Joshua M. Rosenow, Scott E. Cooper, Michael C. Park, Suketu M. Khandhar, Mark Sedrak, Fenna T. Phibbs, Julie G. Pilitsis, Ryan J. Uitti, Philip A. Starr - The Lancet Neurology 2020 cited by 151

  10. Alterations of T-lymphocyte populations in Parkinson disease

    Authors: , , , , - Parkinsonism & Related Disorders 2005 cited by 339

  11. The limbic and neocortical contribution of α‐synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies

    Authors: , , , , , , , , , , , , - Alzheimer s & Dementia 2017 cited by 110

  12. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2006 cited by 578

  13. When DLB, PD, and PSP masquerade as MSA

    Authors: , , , , , , , , - Neurology 2015 cited by 352

  14. Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2024 cited by 70

  15. Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Q. Trojanowski, Virginia M.‐Y. Lee, Karen Marder, D. James Surmeier, Zbigniew K. Wszołek, Serge Przedborski, Dimitri Krainc, Ted M. Dawson, Ole Isacson - Science Translational Medicine 2012 cited by 506

  16. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian R. Mackenzie, Bruce L. Miller, Bradley F. Boeve, Steven G. Younkin, Dennis W. Dickson, Ronald C. Petersen, Neill R. Graff‐Radford, Daniel H. Geschwind, Rosa Rademakers - Neurology 2010 cited by 247

  17. Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci

    Authors: , , , , , , , , , , , , , , , - Molecular Neurodegeneration 2018 cited by 102

  18. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven E. Arnold, John Q. Trojanowski, Virginia M. Lee, Gregor K. Wenning, Charles L. White, Günter U. Höglinger, Ulrich Müller, Bernie Devlin, Lawrence I. Golbe, Julia E. Crook, Joseph E. Parisi, Bradley F. Boeve, Keith A. Josephs, Zbigniew K. Wszołek, Ryan J. Uitti, Neill R. Graff‐Radford, Irene Litvan, Steven G. Younkin, Li-San Wang, Nilüfer Ertekin‐Taner, Rosa Rademakers, Hakon Hakonarsen, Gerard D. Schellenberg, Dennis W. Dickson - Nature Communications 2015 cited by 241

  19. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies

    Authors: , , , , , , , , , , , , , , , - Neurology 2013 cited by 233

  20. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dieter Edbauer, Sigrun Roeber, Janine Diehl‐Schmid, Bret M. Evers, Andrew King, Marsel Mesulam, Sandra Weıntraub, Changiz Geula, Kevin F. Bieniek, Leonard Petrucelli, Geoffrey L. Ahern, Eric M. Reiman, Bryan K. Woodruff, Richard J. Caselli, Edward D. Huey, Martin R. Farlow, Jordan Grafman, Simon Mead, Lea T. Grinberg, Salvatore Spina, Murray Grossman, David J. Irwin, Edward B. Lee, EunRan Suh, Julie S. Snowden, David Mann, Nilüfer Ertekin‐Taner, Ryan J. Uitti, Zbigniew K. Wszołek, Keith A. Josephs, Joseph E. Parisi, David S. Knopman, Ronald C. Petersen, John R. Hodges, Olivier Piguet, Ethan G. Geier, Jennifer S. Yokoyama, Robert A. Rissman, Ekaterina Rogaeva, Julia Keith, Lorne Zinman, Maria Carmela Tartaglia, Nigel J. Cairns, Carlos Cruchaga, Bernardino Ghetti, Julia Kofler, Oscar L. López, Thomas G. Beach, Thomas Arzberger, Jochen Herms, Lawrence S. Honig, Jean Paul Vonsattel, Glenda M. Halliday, John B. Kwok, Charles L. White, Marla Gearing, Jonathan D. Glass, Sara Rollinson, Stuart Pickering‐Brown, Jonathan D. Rohrer, John Q. Trojanowski, Vivianna Van Deerlin, Eileen H. Bigio, Claire Troakes, Safa Al‐Sarraj, Yan W. Asmann, Bruce L. Miller, Neill R. Graff‐Radford, Bradley F. Boeve, William W. Seeley and 5 more - Acta Neuropathologica 2019 cited by 128

  21. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rejko Krüger, Elli Kyratzi, Suzanne Lesage, Chin‐Hsien Lin, Timothy Lynch, Demetrius M. Maraganore, George D. Mellick, Eugénie Mutez, Christer Nilsson, Grzegorz Opala, Sung Sup Park, Andreas Puschmann, Aldo Quattrone, Manu Sharma, Peter A. Silburn, Young H. Sohn, Leonidas Stefanis, Vera Tadić, Jessie Theuns, Hiroyuki Tomiyama, Ryan J. Uitti, Enza Maria Valente, Simone van de Loo, Demetrios K. Vassilatis, Carles Vilariño‐Güell, Linda R. White, Karin Wirdefeldt, Zbigniew K. Wszołek, Ruey‐Meei Wu, Matthew J. Farrer - The Lancet Neurology 2011 cited by 344

  22. Neuroimaging Advances in Deep Brain Stimulation: Review of Indications, Anatomy, and Brain Connectomics

    Authors: , , , , , , , , , , , , , - American Journal of Neuroradiology 2020 cited by 129

  23. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy

    Authors: , , , , , , , , , , , , , , , , , , - Movement Disorders 2019 cited by 151

  24. Connectivity correlates to predict essential tremor deep brain stimulation outcome: Evidence for a common treatment pathway

    Authors: , , , , , , , , , , , , , , , , - NeuroImage Clinical 2021 cited by 56